Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications P. H. YuD. M. Zuo Originals Pages: 1243 - 1250
Possible role of free radicals generated by pseudohypoxia in the regulation of hepatic glucose output. An in vitro model using rat liver microsomal glucose 6-phosphatase I. WittmannI. MazákJ. Nagy Originals Pages: 1251 - 1254
Changes in the expression of Na+/K+-ATPase isoenzymes in the left ventricle of diabetic rat hearts: effect of insulin treatment Á VérI. SzántóJ. Somogyi Originals Pages: 1255 - 1262
Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin R. B. FraserG. RowdenJ. R. Wright Originals Pages: 1263 - 1268
Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia A. SainsburyF. Rohner-JeanrenaudB. Jeanrenaud Originals Pages: 1269 - 1277
Effects of 4 weeks’ administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations R. G. ThompsonL. PearsonO. G. Kolterman Originals Pages: 1278 - 1285
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X J. C. PickupM. B. MattockD. Burt Originals Pages: 1286 - 1292
Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM A. DoriaT. OnumaA. S. Krolewski Originals Pages: 1293 - 1299
Evidence that insulin can directly inhibit hepatic glucose production P. MaheuxY. D. I. ChenG. M. Reaven Originals Pages: 1300 - 1306
Cardiac disease in diabetic end-stage renal disease R. N. FoleyB. F. CulletonPaul E. Barre Originals Pages: 1307 - 1312
New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland J. RissanenJ. PihlajamäkiM. Laakso OriginalPaper Pages: 1313 - 1319
Protracted glucose fall in subcutaneous adipose tissue and skeletal muscle compared with blood during insulin-induced hypoglycaemia E. MobergE. Hagström-ToftJ. Bolinder OriginalPaper Pages: 1320 - 1326
Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM E. C. I. HatfieldC. J. HawkesM. R. Christie OriginalPaper Pages: 1327 - 1333
Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study J. J. J. de SonnavilleM. BoumaR. J. Heine OriginalPaper Pages: 1334 - 1340
Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II study E. J. BrunnerM. G. MarmotK. G. M. M. Alberti OriginalPaper Pages: 1341 - 1349
The JEVIN trial: A population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990 R. SchielU. A. MüllerI. S. Ross OriginalPaper Pages: 1350 - 1357
Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways M. KellererM. KochH. U. Häring Rapid communication Pages: 1358 - 1362
Factor V Leiden mutation and Japanese NIDDM M. OdawaraK. Yamashita Letters to the editor Pages: 1363 - 1364
Anti-ganglioside GM1 antibody and distal symmetric “diabetic polyneuropathy” with dominant motor features Letters to the editor Pages: 1364 - 1365
Preliminary data on a genome search in NIDDM siblings: the NIDDM 1 locus on chromosome 2 is not linked to NIDDM in the Sardinian population M. CiccareseG. TonoloStudy Group for the Genetics of Diabetes in Sardinia Letters to the editor Pages: 1366 - 1367
Glucokinase deficiency results in a beta-cell disorder characterised by normal fasting plasma proinsulin concentrations A. T. HattersleyP. M. ClarkR. C. Turner Letters to the editor Pages: 1367 - 1368